Abstract
In this chapter introducing the results of the discussions that took place in the consensus meeting on portal hypertension held on April 10–11, 2015 in Baveno, Italy, the Japanese guidelines published in 2016 are compared with the Baveno consensus on portal hypertension. The Baveno VI workshop honors the 25th anniversary of its organizer Prof. Roberto de Franchis.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Franchis R, editor. Portal hypertension VI: proceedings of the sixth Baveno consensus workshop; stratifying risk and individualizing care. Springer; 2016.
Tsochatzis EA, Bosch J, Burrough AK. Liver cirrhosis. Lancet. 2014;383(9930):1749–61.
Franchis R, Baveno VI Faculty. Expanding consensus in portal hypertension. J Hepatol. 2015;63:743–52.
Thabut D, Rudler M, Dib N, Carbonell N, Mathurin P, Saliba F, et al. Multicenter prospective validation of Baveno IV and Baveno II/III criteria in cirrhosis patients with variceal bleeding. Hepatology. 2015;61:1024–32.
Ahn SY, Park SY, Tak WY, Lee YR, Kang EJ, Park JG, et al. Prospective validation of Baveno V definitions and criteria for failure to control bleeding in portal hypertension. Hepatology. 2015;61:1033–40.
Jepsen P, Vilstrup H, Andersen PK. The clinical course of cirrhosis; the importance of multi-state models and competing analysis. Hepatology. 2015;62(1):292–302. https://doi.org/10.1002/hep.27598.
Jepsen P. Comorbidity in cirrhosis. World J Gastroenterol. 2014;20:7223–30.
Kudo M, Shiina T, Moriyasu F, Iijima H, Tateishi R, Yada N, et al. JSUM ultrasound elastography practice guidelines: liver. J Med Ultrason. 2013;40:325–57.
Villa E, Camma C, Marietta M, Luongo M, Critelli R, Colopi S, et al. Enoxaparin prevents portal vein thrombosis and liver decompensation in patients with advanced cirrhosis. Gastroenterology. 2012;143:1253–60.
Vlachogiannakos J, Viazis N, Vasianopoulou P, Vafiadis I, Karamanolis DG, Ladas SD. Long-term administration of rifaximin improves the prognosis of patients with decompensated alcoholic cirrhosis. J Gastroenterol Hepatol. 2013;28(3):450–5.
Fukui H, Saito H, Ueno Y, Uto H, Obara K, Sakaida I, et al. Evidence-based clinical practice guidelines for liver cirrhosis 2015. J Gastroenterol. 2016;51:629–50.
Iso Y, Kawanaka H, Tomikawa M. Repeated injection sclerotherapy is preferable to combined therapy with variceal ligation to avoid recurrence of esophageal varices; a prospective randomized trial. Hepato-Gastroenterology. 1997;44:467–71.
Gotoh Y, Iwakiri R, Sakata Y, Koyama T, Noda T, Matsunaga C, et al. Evaluation of endoscopic variceal ligation in prophylactic therapy for bleeding of oesophageal varices; a prospective, controlled trial compared with endoscopic injection sclerotherapy. J Gastroenterol Hepatol. 1999;14:241–4.
Akahoshi T, Tomikawa M, Tsutsumi N, Hashizume M, Maehara Y. Merits of prophylactic sclerotherapy for esophageal varices concomitant unresectable hepatocellular carcinoma; prospective randomized study. Dig Endosc. 2014;26:172–7.
Sauerbruch T, Mengel M, Dollinger M, et al. German Study Group for Prophylaxis of Variceal Rebleeding. Prevention of rebleeding from esophageal varices in patients with cirrhosis receiving small-diameter stents versus hemodynamically controlled medical therapy. Gastroenterology. 2015;149(3):528–31.
Sabri SS, Abi-Jaoudeh N, Swee W, Saad WE, Turba UC, Caldwell SH, et al. Short-term rebleeding rates for isolated gastric varices managed by transjugular intrahepatic portosystemic shunt versus balloon-occluded retrograde transvenous obliteration. J Vasc Interv Radiol. 2014;25:355–61.
Lee SJ, Kim SU, Kim MD, Kim YH, Kim GM, Park SI, et al. Comparison of treatment outcomes between balloon-occluded retrograde transvenous obliteration and transjugular intrahepatic portosystemic shunt for gastric variceal bleeding hemostasis. J Gastroenterol Hepatol. 2017;32(8):1487–94. https://doi.org/10.1111/jgh.13729.
Kobayakawa M, Kokubu S, Hirota S, Koizumi J, Nishida N, Yasumoto T, et al. Short-term safety and efficacy of balloon-occluded retrograde transvenous obliteration using ethanolamine oleate; results of a prospective, multicenter, single-arm trial. J Vasc Interv Radiol. 2017;28(8):1108–15. https://doi.org/10.1016/j.jvir.2017.03.041. pii: S1051-0443(17)30378-0
Hubmann R, Bodlaj G, Czompo M, Benko L, Pichler P, Al-Kathib S, et al. The use of self-expanding metal stents to treat acute esophageal variceal bleeding. Endoscopy. 2006;38:896–901.
Bass NM, Mullen KD, Sanyal A, Poordad F, Neff G, Leevy CB, et al. Rifaximin treatment in hepatic encephalopathy. N Engl J Med. 2010;362(12):1071–81.
Cardenas A, Mendez-Bocanegra A. Report of the Baveno VI consensus workshop. Ann Hepatol. 2016;15:289–90.
Park JK, Saab S, Kee ST, Busutti RW, Kim HJ, Durazo F, et al. Balloon-occluded retrograde transvenous obliteration (BRTO) for treatment of gastric varices: review and meta-analysis. Dig Dis Sci. 2015;60:1543–53.
Choi YH, Yoon CJ, Park JH, Chung JW, Kwon JW, Choi GM. Balloon-occluded retrograde transvenous obliteration for gastric variceal bleeding: its feasibility compared with transjugular intrahepatic portosystemic shunt. Korean J Radiol. 2003;4:109–16.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2019 Springer Nature Singapore Pte Ltd.
About this chapter
Cite this chapter
Murashima, N. (2019). The Baveno IV Workshop: European Consensus Meeting on Portal Hypertension and Comparison with Japanese Guidelines. In: Obara, K. (eds) Clinical Investigation of Portal Hypertension. Springer, Singapore. https://doi.org/10.1007/978-981-10-7425-7_16
Download citation
DOI: https://doi.org/10.1007/978-981-10-7425-7_16
Published:
Publisher Name: Springer, Singapore
Print ISBN: 978-981-10-7424-0
Online ISBN: 978-981-10-7425-7
eBook Packages: MedicineMedicine (R0)